Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
Deborah Hinnen,1 Davida F Kruger2 1Department of Health and Wellness, Memorial Hospital Diabetes Center, University of Colorado Health, Colorado Springs, CO 80909, USA; 2Henry Ford Health System, Division of Endocrinology, Diabetes, Bone and Mineral Disease, Henry Ford Medical Center – New...
Enregistré dans:
Auteurs principaux: | Hinnen D, Kruger DF |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e201ad0b5d9b4b599fbfa9c4eab0843d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes
par: Liu D, et autres
Publié: (2021) -
Cardiovascular Safety and Superiority of Anti-Obesity Medications
par: Alobaida M, et autres
Publié: (2021) -
Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
par: Palma CCSSV, et autres
Publié: (2020) -
Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
par: Wu YH, et autres
Publié: (2020) -
Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
par: Marina Vladimirovna Shestakova, et autres
Publié: (2016)